These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23426443)

  • 1. Dietary fructose intake and severity of liver disease in hepatitis C virus-infected patients.
    Tyson GL; Richardson PA; White DL; Kuzniarek J; Ramsey DJ; Tavakoli-Tabasi S; El-Serag HB
    J Clin Gastroenterol; 2013 Jul; 47(6):545-52. PubMed ID: 23426443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males.
    White DL; Tavakoli-Tabasi S; Kuzniarek J; Pascua R; Ramsey DJ; El-Serag HB
    Hepatology; 2012 Mar; 55(3):759-68. PubMed ID: 21858849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WNT signaling pathway gene polymorphisms and risk of hepatic fibrosis and inflammation in HCV-infected patients.
    Liu Y; El-Serag HB; Jiao L; Lee J; Moore D; Franco LM; Tavakoli-Tabasi S; Tsavachidis S; Kuzniarek J; Ramsey DJ; White DL
    PLoS One; 2013; 8(12):e84407. PubMed ID: 24386373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between serological and dietary vitamin D levels and hepatitis C-related liver disease risk differs in African American and white males.
    White DL; Tavakoli-Tabasi S; Kanwal F; Ramsey DJ; Hashmi A; Kuzniarek J; Patel P; Francis J; El-Serag HB
    Aliment Pharmacol Ther; 2013 Jul; 38(1):28-37. PubMed ID: 23710689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C.
    Khalaf N; White D; Kanwal F; Ramsey D; Mittal S; Tavakoli-Tabasi S; Kuzniarek J; El-Serag HB
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1521-31.e3. PubMed ID: 25777972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis C infection.
    White DL; Richardson PA; Al-Saadi M; Fitzgerald SJ; Green L; Amaratunge C; Anand M; El-Serag HB
    Dig Dis Sci; 2011 Jun; 56(6):1835-47. PubMed ID: 21188525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients.
    Petta S; Marchesini G; Caracausi L; Macaluso FS; Cammà C; Ciminnisi S; Cabibi D; Porcasi R; Craxì A; Di Marco V
    J Hepatol; 2013 Dec; 59(6):1169-76. PubMed ID: 23933265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finasteride and methadone use and risk of advanced hepatitis C related liver disease.
    White DL; Hashmi A; Ramsey DJ; Kuzniarek J; Tavakoli-Tabasi S; El-Serag HB
    Dig Dis Sci; 2012 Nov; 57(11):3004-10. PubMed ID: 22669204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study on hepatic iron overload in chronic hepatitis C patients].
    Bomfim EA; Pereirade de Oliveira AC; Paraná R; Schinoni MI
    Acta Gastroenterol Latinoam; 2013 Sep; 43(3):212-7. PubMed ID: 24303687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.
    Loguercio C; Federico A; Masarone M; Torella R; Blanco Cdel V; Persico M
    Am J Gastroenterol; 2008 Dec; 103(12):3159-66. PubMed ID: 18786125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: a longitudinal long-term cohort study.
    Kielland KB; Delaveris GJ; Rogde S; Eide TJ; Amundsen EJ; Dalgard O
    J Hepatol; 2014 Feb; 60(2):260-6. PubMed ID: 24096048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
    Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
    Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Hsu SJ; Chen CL; Hwang JJ; Lai MY; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2010 May; 25(5):970-7. PubMed ID: 20546452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis.
    Zeuzem S; Soriano V; Asselah T; Gane EJ; Bronowicki JP; Angus P; Lohse AW; Stickel F; Müllhaupt B; Roberts S; Schuchmann M; Manns M; Bourlière M; Buti M; Stern JO; Gallivan JP; Voss F; Sabo JP; Böcher W; Mensa FJ;
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1282-91. PubMed ID: 25512403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of liver surface nodularity quantification on MDCT for staging hepatic fibrosis in patients with hepatitis C virus.
    Lubner MG; Jones D; Said A; Kloke J; Lee S; Pickhardt PJ
    Abdom Radiol (NY); 2018 Nov; 43(11):2980-2986. PubMed ID: 29572714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection.
    Jiménez-Sousa MA; Berenguer J; Rallón N; Pineda-Tenor D; Aldamiz-Echevarria T; Soriano V; García-Álvarez M; Vazquez-Morón S; Restrepo C; Carrero A; Benito JM; Resino S
    Liver Int; 2016 Sep; 36(9):1258-66. PubMed ID: 26836972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex difference in liver-related mortality and transplantation associated with dietary cholesterol in chronic hepatitis C virus infection.
    Yu L; Morishima C; Ioannou GN
    Br J Nutr; 2016 Jan; 115(2):193-201. PubMed ID: 26541123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Steatosis and non-alcoholic steatohepatitis in patients with chronic hepatitis due to hepatitis C virus infection].
    Coral G; de Mattos AA; de Mattos AZ; dos Santos DE
    Arq Gastroenterol; 2006; 43(4):265-8. PubMed ID: 17406752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
    Manchiero C; Nunes AKDS; Magri MC; Dantas BP; Mazza CC; Barone AA; Tengan FM
    BMC Infect Dis; 2017 Dec; 17(1):780. PubMed ID: 29258449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
    Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
    J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.